S-1 · primary offering
Issued 2023
Proposed maximum
Shares registered
- Filed
- Effective
SNGX$0.359-0.61%
Soligenix, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$7.81M
Float & O/S:
Inst Own:
DilutionScan read 26 of SOLIGENIX, INC.'s SEC filings and found 5 warrant series, 1 convertible, 3 ATM programs, 1 shelf registration, 4 S-1 registrations and 1 completed offering on file for SNGX. The latest dilution event on file is ATM sales on Jul 31, 2026. Analysis updated Oct 11, 2026.
Signal8 Summary
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 95 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 31, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
May 2023 public offering common warrants ( issued May 9, 2023)
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
April 2024 public offering common warrants ( issued April 22, 2024)
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Common warrants dated September 25, 2025
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
September 2025 public offering common warrants ( issued September 29, 2025)
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
September 2025 public offering pre-funded warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2017
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2023
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your SNGX trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
